Professor Peter John Browett

BMedSci, MBChB, FRACP, FRCPA

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Desai, R., Taghavi, S., Chase, J. C., Chopra, M., Chien, J., Browett, P. J., ... Bohlander, S. K. (2020). Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a andCALM/AF10. Leukemia, 34 (6), 1706-1710. 10.1038/s41375-019-0657-8
    Other University of Auckland co-authors: Rhea Desai, Stefan Bohlander, Purvi Kakadiya
  • Rees, M. J., Spencer, A., Browett, P., Alvaro, F., Purtill, D., Crawford, J., ... Grigg, A. (2020). High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission. Bone marrow transplantation10.1038/s41409-020-0924-3
  • Chien, N., Varghese, C., Green, T. N., Chan, G., Theakston, E., Eaddy, N., ... Browett, P. J. (2020). Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience. Leukemia research, 9310.1016/j.leukres.2020.106358
    Other University of Auckland co-authors: Maggie Kalev
  • Angelucci, E., Li, J., Greenberg, P., Wu, D., Hou, M., Montano Figueroa, E. H., ... Izquierdo, M. (2020). Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial. Annals of internal medicine, 172 (8), 513-522. 10.7326/m19-0916
  • Kulasekararaj, A., Risitano, A., Maciejewski, J., Notaro, R., Browett, P., Lee, J. W., ... Brodsky, R. (2020). A phase 2 open-label study of danicopan (ACH-0144471) in patients with paroxysmal nocturnal haemoglobinuria who have an inadequate response to eculizumab monotherapy. Paper presented at 60th Annual Scientific Meeting of the British-Society-for-Haematology (BSH), Birmingham, ENGLAND. 27 April - 29 April 2020. BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2).
  • van Kan, M., Burns, K. E., Browett, P., & Helsby, N. A. (2019). A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells. Scientific Reports, 910.1038/s41598-019-55161-3
    Other University of Auckland co-authors: Maia van Kan, Katie Burns, Nuala Helsby
  • Molloy, B., Marty Francisco, M., Ellison Misoo, C., Rabitsch, W., Itaelae-Remes, M., Dominietto, A., ... Leavitt Randi, Y. (2019). RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CLINICALLY SIGNIFICANT CYTOMEGALOVIRUS (CMV) INFECTION IN ALLOGENEIC PROGENITOR TRANSPLANTATION. Paper presented at 61st National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy, Valencia, SPAIN. 24 October - 26 October 2019. HAEMATOLOGICA. (pp. 1).
  • Risitano, A., Kulasekararaj, A., Lee, J. W., Notaro, R., Brodsky, R. A., Huang, M., ... Browett, P. (2019). A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH). Paper presented at 47th Congress of the Italian-Society-of-Hematology, Rome, ITALY. 7 October - 9 October 2019. HAEMATOLOGICA. (pp. 1).

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 3, Room 339
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand